- Scrip Originals
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Vical Inc.
Meeting all primary and secondary endpoints in a pair of pivotal trials, Brickell says sofpironium bromide gel will be ready for FDA filing in mid-2022. The topical is already approved in Japan as Ecclock.